Fall Risk and Quality of Life: in Individuals With Cancer Treatment Related Peripheral Neuropathy.

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorTexas Woman's University

About this trial

The purpose of this research is to examine the impact of peripheral neuropathy on fall risk and quality of life in people who had cancer and neuropathy from cancer treatments. The investigators are interested to find out if the participant have any difficulty with thinking, feeling, balancing, or moving around that will contribute to risk for falls or quality of life. Investigators are also interested to see if the participants have any difficulty with doing two activities at the same time, such as walking and texting.

Eligibility criteria

Qualifiers

Individuals 18 years and older

diagnosed with non- CNS cancer who underwent treatment and presents with peripheral neuropathy symptoms.

age (+/- one year) and gender matched individuals

no diagnosed peripheral neuropathy

Disqualifiers

Unable to follow two step commands.

Unable to ambulate x 50 feet independently without use of an assistive device.

Unable to use a phone to send text messages.

Diagnosis of diabetic peripheral neuropathy

Trial design

Treatments tested in this trial

  • Not listed

Trial groups

40 Participants
are grouped into 2 trial groups

Sponsors and collaborators